Abstract
Background
Inferior vena cava (IVC) leiomyosarcomas (LMS) are a rare group of retroperitoneal tumors. R0 surgical resection is the only curative modality of treatment. IVC resection for retroperitoneal sarcoma is a complex surgery with no definitive guidelines for reconstruction.
Methods
Retrospective review of all patients who underwent surgical resection of primary leiomyosarcoma of the IVC requiring resection from 2010 to 2020 at our tertiary care center was performed.
Results
Among 24 patients who required IVC resection for LMS, only 7 (29%) required reconstruction of IVC. According to Clavien-Dindo classification, there was one grade 3 or more morbidity and 1 post-operative mortality. Seventeen patients underwent R0 resection whereas 7 patients had R1 resection on final histopathology. At a median follow-up of 25 months (range 8–91 months), the median OS was 40 months with median DFS of 28 months. Two patients presented with local recurrence while 13 patients developed systemic recurrence on follow-up.
Conclusion
Careful preoperative multidisciplinary planning can make IVC resection without reconstruction feasible with acceptable perioperative morbidity, mortality, and oncological outcomes for IVC LMS.
Similar content being viewed by others
References
Penel N, Coindre J-M, Toulmonde M, Blay J-Y (2017) Presentation and outcome of frequent and rare sarcoma histologic subtypes: a study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers. Cancer 124(6):1179–1187
Alkhalili E, Greenbaum A, Langsfeld M, Marek J, Rana MA, Glew R et al (2016) Leiomyosarcoma of the inferior vena cava: a case series and review of the literature. Ann Vasc Surg 33:245–251
Kieffer E, Alaoui M, Piette JC et al (2006) Leiomyosarcoma of the inferior vena cava: experience in 22 cases. Ann Surg 244:289–295
Dzsinich C, Gloviczki P, van Heerden JA et al (1992) Primary venous leiomyosarcoma : a rare but lethal disease. J Vasc Surg 15:595–603
Perl L (1871) Ein Fall von Sarkom der Vena Cava inferior. Arch path Anat 53:378e83
Cope JS, Hunt CJ (1954) Leiomyosarcoma of inferior vena cava. AMA Arch Surg 68:752e6
Burke AP, Virmani R (1993) Sarcomas of the great vessels. A clinico-pathologic study Cancer 71:1761–1773
Hollenbeck ST, Grobmyer SR, Kent KC, Brennan MF (2003) Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma. J Am Coll Surg 197(4):575–579
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196. https://doi.org/10.1097/SLA.0b013e3181b13ca2
Wachtel H, Gupta M, Bartlett EK, Jackson BM, Kelz RR, Karakousis GC et al (2015) Outcomes after resection of leiomyosarcomas of the inferior vena cava: a pooled data analysis of 377 cases. Surg Oncol 24(1):21–27
Mastoraki A, Leotsakos G, Mastoraki S, Papanikolaou IS, DaniasN SV et al (2015) Challenging diagnostic and therapeutic modalities for leiomyosarcoma of inferior vena cava. Int J Surg Lond Engl 13:92–95
Gaignard E, Bergeat D, Robin F et al (2020) Inferior vena cava leiomyosarcoma: what method of reconstruction for which type of resection? World J Surg 44:3537–3544. https://doi.org/10.1007/s00268-020-05602-2
Tzanis D, Bouhadiba T, Gaignard E, Bonvalot S (2018) Majorvascular resections in retroperitoneal sarcoma. J Surg Oncol 117(1):42–47
Jiang H, Wang Y-X, Li B, Jiang Y-Y, Miao C-L, Liao D-X et al (2015) Surgical management of leiomyosarcoma of the inferior vena cava. Vascular 23(3):329–332
Kalchev E, Popova RD, Valchev G, Balev B; Varna/BG: Congenital absence of inferior venacava. ECR2015. 10.1594/ecr2015/C-1980
Quinones-Baldrich W, Alktaifi A, Eilber F, Eilber F (2012) Inferior vena cava resection and reconstruction for retroperitoneal tumor excision. J Vasc Surg 55(5):1386–1393
Fiore M (2012) Surgical technique, morbidity, and outcome of primary retroperitoneal sarcoma involving inferior vena cava. Ann Surg Oncol 19:511–518
Ito H, Hornick JL, Bertagnolli MM et al (2007) Leiomyosarcoma of the inferior vena cava: survival after aggressive management. Ann Surg Oncol 14(12):3534–3541
Mann GN, Mann LV, Levine EA, Shen P (2012) Primary leiomyosarcoma of 2- the inferior vena cava: a institution analysis of outcomes. Surgery 151(2):261–267
Joung HS, Nooromid MJ, Eskandari MK, Wayne JD (2020) Surgical approach, management, and oncologic outcomes of primary leiomyosarcoma of the inferior vena cava: an institutional case series. J Surg Oncol 1–8
Bonvalot S, Gronchi A, Le Péchoux C et al (2020) Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 21(10):1366–1377. https://doi.org/10.1016/S1470-2045(20)30446-0
Jeong S, Han Y, Cho YP, Kwon TW (2019) Clinical outcomes of surgical resection for leiomyosarcoma of the inferior vena cava. Ann Vasc Surg. 61:377–383
Nussbaum DP, Rushing CN, Lane WO et al (2016) Preoperative or post operative radiotherapy versus surgery alone for retroperitoneal sarcoma case-control, propensity -matched analysis of a nationwide clinical oncology database. Lancet Oncol 17(7):966–975
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Name of the institute where study was performed: GI & HPB Service, Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Goel, M., Mohan, A., Patkar, S. et al. Leiomyosarcoma of inferior vena cava (IVC): do we really need to reconstruct IVC post resection? Single institution experience. Langenbecks Arch Surg 407, 1209–1216 (2022). https://doi.org/10.1007/s00423-021-02408-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-021-02408-1